Special Issue "Cancer and Chronic Illness"
Deadline for manuscript submissions: 30 June 2024 | Viewed by 2925
Interests: cancer; artificial intelligence
Cancer has been increasingly classified as a chronic disease, sharing many risk factors with the most common chronic disorders, such as aging and an unhealthy lifestyle, underlying which an inflammatory substrate is recognized. In addition to being major causes of death and disability, some chronic diseases can also predispose to cancer and thus be considered independent risk factors. Advances in the field of drug discovery and the development of novel life-prolonging strategies have led to an increase in extended treatments involving immunotherapy, targeted therapy, radiation therapy, and hormone therapy, which, while not being able to cure the disease, can nevertheless control it for months or even years, thus exposing patients to chronic-treatment-related toxicities. In addition, many cancer patients will inevitably suffer from chronic comorbid conditions that pose a major challenge for the overall clinical management. Moreover, it has been found in many settings that chronic comorbid conditions might play a role as both prognostic and predictive factors influencing patient outcome and response to treatment.
This Special Issue will focus on the importance of chronic conditions both as sequelae of anticancer therapies and as influencing factors of the disease natural history and treatment sensitivity. Recent advances in understanding the multiple interconnections among cancer and chronic illnesses with potential effects on the trajectory of cancer burden and patient prognosis will be described.
Dr. Silvia Riondino
Dr. Vincenzo Formica
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chronic disease
- inflammatory disease
- immune disease
- radiotherapy-induced diseases
- immunotherapy-induced disease
- gastrointestinal chronic disorders
- end-stage renal disease
- lung cancer chronic disease